این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Pathology، جلد ۸، شماره ۴، صفحات ۲۴۷-۲۵۴
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی DNA Load Analysis Using Real Time PCR In Comparison With Immunohistochemical Findings of Dry Type Cutaneous Leishmaniasis; Before and After Treatment by Imiquimode,Glucantime and Combination of Both Drugs
چکیده انگلیسی مقاله Background and Objectives: Kerman Province, especially city of Bam in the southeast part of Iran, is epidemics for dry type cutaneous leishmaniasis (DTCL). This study was conducted to compare the effect of different treatments on parasite DNA load following therapies using Real-Time PCR method. Materials and Methods: Fifteen patients were divided into three groups under therapy with intralesional meglumine antimoniate, topical imiquimod and combination of both drugs. After obtaining consent from patients, punch biopsies were taken before and after treatment .To compare the amount of DNA load a relative quantitative Real-Time PCR method was designed and set up using Leishmania tropica ITS (internal transcribed spacer) gene. After doing PCR, the obtained results were analyzed using 2^-ΔΔCT method and relativity of DNA load before and after treatment were calculated. Results: The highest falling of DNA load was for imiquimod (mean 4/7 cases), glucantime (mean 2/2 cases) and combination therapy (mean 2/4). From clinical point of view combination therapy had the best response. On the other hand, the overall IHC findings showed good response based on decreased CD1a epidermal, increased CD1a dermal, decreased CD68 macrophages and increased CD3 and CD20 of dermis. Conclusion: We set up a new method to compare Leishmania DNA load using the stable human gene of beta actin for normalization. We concluded that imiquimod was immune modulator and had synergistic effects on the best parasitocidal drug of glucantime for better response.
کلیدواژه‌های انگلیسی مقاله Leishmania tropica,Real time PCR,Glucantime,Imiquimod
نویسندگان مقاله شهریار دبیری |
dept. of pathology, leishmania research center, afzalipour medical school, kerman university of medical science, kerman, iran

حسن منافی اناری | manafi anari
dept. of pathology, afzalipour medical school, kerman university of medical science, kerman, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (Kerman university of medical sciences)

سیمین شمسی میمندی | shamsi meymandi
dept. of dermatology, afzalipour medical school, kerman university of medical science, kerman, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (Kerman university of medical sciences)

رضا فتوحی اردکانی | fotouhi ardakani
dept. of biotechnology, pasteur institute of iran, tehran, iran amp; shahid-sadoughi university of medical sciences, yazd, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (Kerman university of medical sciences)

سحر امیرپور رستمی | amirpour rostami
pharmaceutics research center, kerman university of medical science, kerman, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (Shahid sadooghi university of medical sciences)

منظومه شمسی میمندی | manzumeh shamsi
dept. of pharmacology, afzalipour medical school, kerman university of medical science, kerman, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (Kerman university of medical sciences)

پریکا لا vijayananda کومار | vijayananda kumar
dept. of pathology, shiraz university of medical sciences, shiraz, iran
سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (Kerman university of medical sciences)

نشانی اینترنتی http://ijp.iranpath.org/article_8251_811686338a44d5fd6a6a571b3f504ab8.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده 1
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات